Eli Lilly and Company (NYSE:LLY) is one of the best future stocks to buy for the long term. On January 8, Eli Lilly announced ...

Swiss pharma giant Roche Holding AG's RHHBY 2025 results were affected by currency headwinds. Sales totaled $74.4 billion, which missed the Zacks Consensus Estimate of $81.4 billion. Earnings per ...

Pharmaceutical company Eli Lilly (LLY) has announced plans to invest more than $3.5 billion to construct a new manufacturing facility in Pennsylvania's Lehigh Valley. This ...

Novo Nordisk A/S Q3 costs, Q4 savings, and oral Wegovy launch drive EPS upside. Click for this NVO stock update and earnings preview.

The sizzle is the excitement about the hunt for the next big blockbuster, and the only one that anyone sees on the horizon is ...

By Bhanvi Satija and Maggie Fick LONDON, Jan 16 (Reuters) - Novo Nordisk's Wegovy weight-loss pill has made an encouraging ...

Hong Kong biotech Ascletis (HKEX: 1672) has picked ASC37 injection, a once-monthly, subcutaneous triple agonist, as a ...

Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just ...

We look at the Novo Nordisk A/S outlook for 2026: new CEO focus, oral Wegovy edge vs Eli Lilly, and double-digit growth ...

Eli Lilly and Company’s LLY stock declined 3.8% on Thursday after the FDA reportedly delayed its decision on LLY’s ...

New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound ...

Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.